Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 2, 2002

View Archived Issues

Beta-glucan and 3F8 exert synergistic antitumor effects in athymic mice with neuroblastoma

Ramoplanin and vancomycin bind to different loci in the sequence of proteoglycans

Lower systolic and diastolic blood pressure values in growth hormone replacement patients

VEGF Trap effectively blocks tumor-related angiogenesis in mice

New triple combination induces immunosuppression in transplanted diabetic mice

Piceatannol combined with subtherapeutic ciclosporin increases kidney allograft survival

New data on LF-15-0195 presented at Transplantation Society congress

Pulmozyme prevents tissue aggregation during isolation of human pancreatic islets

E.U. approval for Visudyne

Phase IIa trial of AOD-9604 shows positive results

ACS news: novel CRF1 receptor ligands for anxiety and depression

Merck & Co. presents growth hormone-secreting compounds at ACS

Maxygen receives grant to develop cross-protective encephalitis vaccines

FTY-720 a highlight at the Transplantation Society congress

Phase II/III Fibrillex trial cleared by review board

Oxagen inlicenses diagnostic markers for osteoporosis

Modafinil approved in Australia, New Zealand and Korea

Intranasal ketamine proves rapid, safe and effective relief for breakthrough pain

DB-289 to enter phase IIa trial in malaria

Lexapro approved for treatment and maintenance treatment of major depressive disorder

Neurochem files IND for Alzhemed

Telomerase inhibitors developed jointly by Geron and Kyowa Hakko

Long-acting bronchodilators emerge from research at Almirall Prodesfarma

New series of CB2 receptor ligands described by Japanese lab

Glutamate receptor antagonists designed by Lilly